NavinPintoMD

Pediatric Hematology & Oncology • Aurora, CO

Pediatric Solid Tumor Oncology

Physician

Join to view full profile

Dr. Pinto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pinto's full profile

Already have an account?

Office
13123 E 16th Ave
Aurora, CO 80045

Education & Training

Saint Louis University School of MedicineClass of 2005

Certifications & Licensure

CO State Medical License 2023 - 2025
WA State Medical License 2015 - 2024
ID State Medical License 2021 - 2023
IL State Medical License 2005 - 2017
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with 4hydroxycyclophosphamide formation in children with Cancer.
Sandi L Navarro, Navin Pinto, Douglas S Hawkins, Julie R Park, Saam Dilmaghani
Cancer Chemotherapy and Pharmacology. 2024-10-01
Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy Activities.
Nicholas A Vitanza, Michelle Choe, Christopher Brown, Adam Beebe, Ada Kong
Journal of Hematology Oncology Pharmacy. 2024-08-01
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.
Navin Pinto, Catherine M Albert, Mallory R Taylor, Heidi B Ullom, Ashley L Wilson
Journal of Clinical Oncology. 2024-09-10

Press Mentions

Q&A: CAR T Cell Therapy Offers a Novel Approach to Pediatric Cancer TreatmentAugust 8th, 2024